| Bioactivity | SC-VC-PAB-N-Me-L-Ala-Maytansinol (compound B1) can be used to synthesis MCC-Maytansinoid A. SC-VC-PAB-N-Me-L-Ala-Maytansinol can be used as a control compound for the cancer research[1]. | ||||||||||||
| Name | SC-VC-PAB-N-Me-L-Ala-Maytansinol | ||||||||||||
| CAS | 2226467-76-9 | ||||||||||||
| Formula | C65H89ClN10O20 | ||||||||||||
| Molar Mass | 1365.91 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. ANDREEV JULIAN, et al. BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND HER2, AND METHODS OF USE THEREOF. WO2021174113. 2021. |
SC-VC-PAB-N-Me-L-Ala-Maytansinol
CAS: 2226467-76-9 F: C65H89ClN10O20 W: 1365.91
SC-VC-PAB-N-Me-L-Ala-Maytansinol (compound B1) can be used to synthesis MCC-Maytansinoid A. SC-VC-PAB-N-Me-L-Ala-Maytans
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.